A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
Clinical trial NCT06337630 · TERMINATED
Trial details
- NCT number
- NCT06337630
- Sponsor
- Institut Curie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-20
- Primary completion
- 2025-11-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.